Viridian Therapeutics, Inc. (VRDN)
NASDAQ: VRDN · IEX Real-Time Price · USD
15.40
+0.82 (5.62%)
May 3, 2024, 4:00 PM EDT - Market closed
Viridian Therapeutics Employees
Viridian Therapeutics had 94 employees on December 31, 2023. The number of employees increased by 8 or 9.30% compared to the previous year.
Employees
94
Change (1Y)
8
Growth (1Y)
9.30%
Revenue / Employee
$3,340
Profits / Employee
-$2,529,085
Market Cap
982.87M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 94 | 8 | 9.30% |
Dec 31, 2022 | 86 | 36 | 72.00% |
Dec 31, 2021 | 50 | 23 | 85.19% |
Dec 31, 2020 | 27 | -19 | -41.30% |
Dec 31, 2019 | 46 | -34 | -42.50% |
Dec 31, 2018 | 80 | 15 | 23.08% |
Dec 31, 2017 | 65 | 20 | 44.44% |
Dec 31, 2016 | 45 | 13 | 40.63% |
Dec 31, 2015 | 32 | 4 | 14.29% |
Dec 31, 2014 | 28 | 16 | 133.33% |
Oct 15, 2013 | 12 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
VRDN News
- 22 hours ago - Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 4 days ago - Viridian Therapeutics to Webcast First Quarter 2024 Financial Results on May 8, 2024 - Business Wire
- 4 weeks ago - Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 5 weeks ago - VIRIDIAN SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Viridian Therapeutics, Inc. (VRDN) and Encourages Investors to Contact the Firm - PRNewsWire
- 2 months ago - Viridian Therapeutics to Participate in the Leerink Partners Global Biopharma Conference - Business Wire
- 2 months ago - Viridian Therapeutics Highlights Recent Progress and Reports Fourth Quarter and Full Year 2023 Financial Results - Business Wire
- 2 months ago - Viridian Therapeutics Appoints Jennifer Tousignant as Chief Legal Officer - Business Wire
- 3 months ago - Viridian Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Business Wire